{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T18:52:53Z","timestamp":1783104773226,"version":"3.54.6"},"reference-count":68,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T00:00:00Z","timestamp":1649721600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Purpose: To conduct a narrative review of research articles on the potential anti- and pro-fibrotic mechanisms of noncoding RNAs following glaucoma filtration surgery. Methods: Keyword searches of PubMed, and Medline databases were conducted for articles discussing post-glaucoma filtration surgeries and noncoding RNA. Additional manual searches of reference lists of primary articles were performed. Results: Fifteen primary research articles were identified. Four of the included papers used microarrays and qRT-PCR to identify up- or down-regulated microRNA (miRNA, miR) profiles and direct further study, with the remainder focusing on miRNAs or long noncoding RNAs (lncRNAs) based on previous work in other organs or disease processes. The results of the reviewed papers identified miR-26a, -29b, -139, -155, and -200a as having anti-fibrotic effects. In contrast, miRs-200b and -216b may play pro-fibrotic roles in filtration surgery fibrosis. lncRNAs including H19, NR003923, and 00028 have demonstrated pro-fibrotic effects. Conclusions: Noncoding RNAs including miRNAs and lncRNAs are emerging and promising therapeutic targets in the prevention of post-glaucoma filtration surgery fibrosis.<\/jats:p>","DOI":"10.3390\/cells11081301","type":"journal-article","created":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T02:48:59Z","timestamp":1649731739000},"page":"1301","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Emerging Evidence of Noncoding RNAs in Bleb Scarring after Glaucoma Filtration Surgery"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5593-3789","authenticated-orcid":false,"given":"Sabrina","family":"Yu","sequence":"first","affiliation":[{"name":"Faculty of Medicine, University of British Columbia, Vancouver, BC V6T 1Z4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex L. C.","family":"Tam","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, Queen\u2019s University, Kingston, ON K7L 3N6, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Campbell","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, Queen\u2019s University, Kingston, ON K7L 3N6, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6695-8236","authenticated-orcid":false,"given":"Neil","family":"Renwick","sequence":"additional","affiliation":[{"name":"Department of Pathology and Molecular Medicine, Queen\u2019s University, Kingston, ON K7L 3N6, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,4,12]]},"reference":[{"key":"ref_1","first-page":"e11686","article-title":"Epidemiology of Glaucoma: The Past, Present, and Predictions for the Future","volume":"12","author":"Allison","year":"2020","journal-title":"Cureus"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0161-6420(97)30174-2","article-title":"Long-Term Follow-up of Initially Successful Trabeculectomy","volume":"104","author":"Chen","year":"1997","journal-title":"Ophthalmology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.ajo.2011.10.026","article-title":"Tube versus Trabeculectomy Study Group. Treatment Outcomes in the Tube Versus Trabeculectomy (TVT) Study after Five Years of Follow-Up","volume":"153","author":"Gedde","year":"2012","journal-title":"Am. J. Ophthalmol."},{"key":"ref_4","first-page":"CD006259","article-title":"Mitomycin C versus 5-Fluorouracil for Wound Healing in Glaucoma Surgery","volume":"2015","author":"Cabourne","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.5005\/jp-journals-10008-1159","article-title":"Wound Healing Modulation in Glaucoma Filtration Surgery\u2013Conventional Practices and New Perspectives: The Role of Antifibrotic Agents (Part I)","volume":"8","author":"Nguyen","year":"2014","journal-title":"J. Curr. Glaucoma Pract."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/j.ophtha.2013.07.049","article-title":"Trabeculectomy in the 21st Century: A Multicenter Analysis","volume":"120","author":"Kirwan","year":"2013","journal-title":"Ophthalmology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/IJG.0b013e31822e8c83","article-title":"Prevention of Ocular Scarring After Glaucoma Filtering Surgery Using the Monoclonal Antibody LT1009 (Sonepcizumab) in a Rabbit Model","volume":"22","author":"Lukowski","year":"2013","journal-title":"J. Glaucoma"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/IJG.0000000000000551","article-title":"Trabeculectomy Combined with Collagen Matrix Implant (Ologen)","volume":"26","author":"Perez","year":"2017","journal-title":"J. Glaucoma"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e16094","DOI":"10.1097\/MD.0000000000016094","article-title":"Ologen Implant versus Mitomycin-C for Trabeculectomy: A Meta-Analysis","volume":"98","author":"Song","year":"2019","journal-title":"Medicine"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e3223","DOI":"10.1097\/MD.0000000000003223","article-title":"The Effects of Bevacizumab in Augmenting Trabeculectomy for Glaucoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"95","author":"Liu","year":"2016","journal-title":"Medicine"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/jhg.2016.91","article-title":"MicroRNAs in Glaucoma and Neurodegenerative Diseases","volume":"62","author":"Molasy","year":"2017","journal-title":"J. Hum. Genet."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cell.2018.03.006","article-title":"Metazoan MicroRNAs","volume":"173","author":"Bartel","year":"2018","journal-title":"Cell"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1126\/science.1138341","article-title":"RNA Maps Reveal New RNA Classes and a Possible Function for Pervasive Transcription","volume":"316","author":"Kapranov","year":"2007","journal-title":"Science"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1152\/physrev.00006.2010","article-title":"MicroRNAs in Development and Disease","volume":"91","author":"Sayed","year":"2011","journal-title":"Physiol. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1373\/clinchem.2010.147405","article-title":"The MicroRNA Spectrum in 12 Body Fluids","volume":"56","author":"Weber","year":"2010","journal-title":"Clin. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1167\/iovs.17-21844","article-title":"Comparison of MicroRNA Expression in Aqueous Humor of Normal and Primary Open-Angle Glaucoma Patients Using PCR Arrays: A Pilot Study","volume":"58","author":"Jayaram","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.preteyeres.2008.11.003","article-title":"MicroRNA Expression in the Eyes and Their Significance in Relation to Functions","volume":"28","author":"Xu","year":"2009","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1111\/febs.14827","article-title":"Long Non-Coding RNAs in Ocular Diseases: New and Potential Therapeutic Targets","volume":"286","author":"Zhang","year":"2019","journal-title":"FEBS J."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Zhang, X., Wang, W., Zhu, W., Dong, J., Cheng, Y., Yin, Z., and Shen, F. (2019). Mechanisms and Functions of Long Non-Coding RNAs at Multiple Regulatory Levels. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20225573"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"BSR20181894","DOI":"10.1042\/BSR20181894","article-title":"Comparison of Cytokine\/Chemokine Levels in Aqueous Humor of Primary Open-Angle Glaucoma Patients with Positive or Negative Outcome Following Trabeculectomy","volume":"39","author":"Stahnke","year":"2019","journal-title":"Biosci. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"111802","DOI":"10.1016\/j.yexcr.2019.111802","article-title":"Role of the Long Noncoding RNA H19 in TGF-\u03921-Induced Tenon\u2019s Capsule Fibroblast Proliferation and Extracellular Matrix Deposition","volume":"387","author":"Zhu","year":"2020","journal-title":"Exp. Cell Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/nrneph.2014.184","article-title":"Targeting CTGF, EGF and PDGF Pathways to Prevent Progression of Kidney Disease","volume":"10","author":"Kok","year":"2014","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/cbf.3382","article-title":"An in Vitro Study of Scarring Formation Mediated by Human Tenon Fibroblasts: Effect of Y-27632, a Rho Kinase Inhibitor","volume":"37","author":"Ibrahim","year":"2019","journal-title":"Cell Biochem. Funct."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.drudis.2019.03.017","article-title":"Causative Glaucoma Treatment: Promising Targets and Delivery Systems","volume":"24","author":"Mietzner","year":"2019","journal-title":"Drug Discov. Today"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Yamanaka, O., Kitano-Izutani, A., Tomoyose, K., and Reinach, P.S. (2015). Pathobiology of Wound Healing after Glaucoma Filtration Surgery. BMC Ophthalmol., 15.","DOI":"10.1186\/s12886-015-0134-8"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.biopha.2018.05.059","article-title":"TGF-\u03922 Induces Proliferation and Inhibits Apoptosis of Human Tenon Capsule Fibroblast by MiR-26 and Its Targeting of CTGF","volume":"104","author":"Bao","year":"2018","journal-title":"Biomed. Pharmacother. Biomed. Pharmacother."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"13342","DOI":"10.1002\/jcp.28011","article-title":"The Smad2\/3\/4 Complex Binds MiR-139 Promoter to Modulate TGF\u03b2-Induced Proliferation and Activation of Human Tenon\u2019s Capsule Fibroblasts through the Wnt Pathway","volume":"234","author":"Deng","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cellsig.2018.11.006","article-title":"Neuroprotective Effects of Overexpressed MicroRNA-200a on Activation of Glaucoma-Related Retinal Glial Cells and Apoptosis of Ganglion Cells via Downregulating FGF7-Mediated MAPK Signaling Pathway","volume":"54","author":"Peng","year":"2019","journal-title":"Cell. Signal."},{"key":"ref_29","first-page":"4799","article-title":"TGF-\u03922 Stimulates Tenon\u2019s Capsule Fibroblast Proliferation in Patients with Glaucoma via Suppression of MiR-29b Expression Regulated by Nrf2","volume":"8","author":"Ran","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1080\/21691401.2017.1345926","article-title":"A Key Role of MicroRNA-26a in the Scar Formation after Glaucoma Filtration Surgery","volume":"46","author":"Wang","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Eissa, M.G., and Artlett, C.M. (2019). The MicroRNA MiR-155 Is Essential in Fibrosis. Non-Coding RNA, 5.","DOI":"10.3390\/ncrna5010023"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1080\/02713683.2018.1549261","article-title":"TGF-\u03921 Induces Human Tenon\u2019s Fibroblasts Fibrosis via MiR-200b and Its Suppression of PTEN Signaling","volume":"44","author":"Tong","year":"2019","journal-title":"Curr. Eye Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.exer.2014.03.008","article-title":"MicroRNA-216b\/Beclin 1 Axis Regulates Autophagy and Apoptosis in Human Tenon\u2019s Capsule Fibroblasts upon Hydroxycamptothecin Exposure","volume":"123","author":"Xu","year":"2014","journal-title":"Exp. Eye Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/hmg\/ddy040","article-title":"Differentially Expressed MicroRNAs in the Aqueous Humor of Patients with Exfoliation Glaucoma or Primary Open-Angle Glaucoma","volume":"27","author":"Drewry","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1038\/cdd.2016.152","article-title":"MicroRNA-26a and -26b Inhibit Lens Fibrosis and Cataract by Negatively Regulating Jagged-1\/Notch Signaling Pathway","volume":"24","author":"Chen","year":"2017","journal-title":"Cell Death Differ."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1167\/iovs.11-9178","article-title":"Discrepant Expression of MicroRNAs in Transparent and Cataractous Human Lenses","volume":"53","author":"Wu","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1167\/iovs.13-13422","article-title":"TGF-\u03921 Stimulates Human Tenon\u2019s Capsule Fibroblast Proliferation by MiR-200b and Its Targeting of P27\/Kip1 and RND3","volume":"55","author":"Tong","year":"2014","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1167\/iovs.11-8670","article-title":"Suppression of Type I Collagen Expression by MiR-29b via PI3K, Akt, and Sp1 Pathway in Human Tenon\u2019s Fibroblasts","volume":"53","author":"Li","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"6019","DOI":"10.1167\/iovs.15-16558","article-title":"Suppression of Type I Collagen Expression by MiR-29b Via PI3K, Akt, and Sp1 Pathway, Part II: An In Vivo Investigation","volume":"56","author":"Yu","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Wang, X., Chen, M., Zeng, L., and Liu, L. (2020). Integrated Aqueous Humor CeRNA and MiRNA-TF-MRNA Network Analysis Reveals Potential Molecular Mechanisms Governing Primary Open-Angle Glaucoma Pathogenesis. bioRxiv.","DOI":"10.1101\/2020.07.17.208397"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"90579","DOI":"10.18632\/oncotarget.21234","article-title":"Interactions between TGF-\u03921, Canonical WNT\/\u03b2-Catenin Pathway and PPAR \u03b3 in Radiation-Induced Fibrosis","volume":"8","author":"Lecarpentier","year":"2017","journal-title":"Oncotarget"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/ijc.27708","article-title":"ZEB\/MiR-200 Feedback Loop: At the Crossroads of Signal Transduction in Cancer","volume":"132","author":"Hill","year":"2013","journal-title":"Int. J. Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.biopha.2018.02.107","article-title":"GRGM-13 Comprising 13 Plant and Animal Products, Inhibited Oxidative Stress Induced Apoptosis in Retinal Ganglion Cells by Inhibiting P2RX7\/P38 MAPK Signaling Pathway","volume":"101","author":"Zhang","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Luna, C., Li, G., Huang, J., Qiu, J., Wu, J., Yuan, F., Epstein, D.L., and Gonzalez, P. (2012). Regulation of Trabecular Meshwork Cell Contraction and Intraocular Pressure by MiR-200c. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0051688"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bbrc.2020.01.096","article-title":"LINC00028 Regulates the Development of TGF\u03b21-Treated Human Tenon Capsule Fibroblasts by Targeting MiR-204-5p","volume":"525","author":"Sui","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1261\/rna.351707","article-title":"The Imprinted H19 Noncoding RNA Is a Primary MicroRNA Precursor","volume":"13","author":"Cai","year":"2007","journal-title":"RNA"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41419-019-1829-1","article-title":"LncRNA NR_003923 Promotes Cell Proliferation, Migration, Fibrosis, and Autophagy via the MiR-760\/MiR-215-3p\/IL22RA1 Axis in Human Tenon\u2019s Capsule Fibroblasts","volume":"10","author":"Zhao","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/jgh.12032","article-title":"Hepatoprotective and Anti-Fibrotic Functions of Interleukin-22: Therapeutic Potential for the Treatment of Alcoholic Liver Disease","volume":"28","author":"Kong","year":"2013","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e2937","DOI":"10.1038\/cddis.2017.292","article-title":"Interleukin-22 Ameliorated Renal Injury and Fibrosis in Diabetic Nephropathy through Inhibition of NLRP3 Inflammasome Activation","volume":"8","author":"Wang","year":"2017","journal-title":"Cell Death Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1101\/gr.082701.108","article-title":"Most Mammalian MRNAs Are Conserved Targets of MicroRNAs","volume":"19","author":"Friedman","year":"2009","journal-title":"Genome Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/978-1-60761-999-4_30","article-title":"Comparison of Microarray and Quantitative Real-Time PCR Methods for Measuring MicroRNA Levels in MSC Cultures","volume":"698","author":"Camarillo","year":"2011","journal-title":"Methods Mol Bol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/jcmm.12236","article-title":"Methodological Challenges in Utilizing MiRNAs as Circulating Biomarkers","volume":"18","author":"Moldovan","year":"2014","journal-title":"J. Cell. Mol. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/bib\/bbp019","article-title":"Expression Profiling of MicroRNAs by Deep Sequencing","volume":"10","author":"Creighton","year":"2009","journal-title":"Brief. Bioinform."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3389\/fphar.2017.00168","article-title":"Retinal and Circulating MiRNAs in Age-Related Macular Degeneration: An In Vivo Animal and Human Study","volume":"8","author":"Romano","year":"2017","journal-title":"Front. Pharmacol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"5665","DOI":"10.1167\/iovs.12-9832","article-title":"Decreased MicroRNA-155 Expression in Ocular Behcet\u2019s Disease but Not in Vogt Koyanagi Harada Syndrome","volume":"53","author":"Zhou","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.gene.2005.12.031","article-title":"LNA-Modified Oligonucleotides Mediate Specific Inhibition of MicroRNA Function","volume":"372","author":"Kauppinen","year":"2006","journal-title":"Gene"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.pharmthera.2011.10.002","article-title":"MicroRNAs in Neurodegenerative Diseases and Their Therapeutic Potential","volume":"133","author":"Junn","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"ref_58","first-page":"114","article-title":"How Close Are MiRNAs from Clinical Practice? A Perspective on the Diagnostic and Therapeutic Market","volume":"30","author":"Bonneau","year":"2019","journal-title":"EJIFCC"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jare.2020.08.012","article-title":"Therapeutic Advances of MiRNAs: A Preclinical and Clinical Update","volume":"28","author":"Chakraborty","year":"2021","journal-title":"J. Adv. Res."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Pfeiffer, N., Voykov, B., Renieri, G., Bell, K., Richter, P., Weigel, M., Thieme, H., Wilhelm, B., Lorenz, K., and Feindor, M. (2017). First-in-Human Phase I Study of ISTH0036, an Antisense Oligonucleotide Selectively Targeting Transforming Growth Factor Beta 2 (TGF-\u03922), in Subjects with Open-Angle Glaucoma Undergoing Glaucoma Filtration Surgery. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0188899"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"CAT-152 0102 Trabeculectomy Study Group, Khaw, P., Grehn, F., Holl\u00f3, G., Overton, B., Wilson, R., Vogel, R., and Smith, Z. (2007). A Phase III Study of Subconjunctival Human Anti-Transforming Growth Factor Beta(2) Monoclonal Antibody (CAT-152) to Prevent Scarring after First-Time Trabeculectomy. Ophthalmology, 114, 1822\u20131830.","DOI":"10.1016\/j.ophtha.2007.03.050"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1167\/iovs.62.15.25","article-title":"The Effect of CHIR 99021, a Glycogen Synthase Kinase-3\u03b2 Inhibitor, on Transforming Growth Factor \u03b2-Induced Tenon Fibrosis","volume":"62","author":"Lee","year":"2021","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/ICO.0000000000000389","article-title":"Identification of Corneal Neovascularization-Related Long Noncoding RNAs through Microarray Analysis","volume":"34","author":"Huang","year":"2015","journal-title":"Cornea"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s12038-016-9636-7","article-title":"Long Non-Coding RNA HOTAIR Regulates Proliferation and Invasion via Activating Notch Signalling Pathway in Retinoblastoma","volume":"41","author":"Dong","year":"2016","journal-title":"J. Biosci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e1506","DOI":"10.1038\/cddis.2014.466","article-title":"Pathogenic Role of LncRNA-MALAT1 in Endothelial Cell Dysfunction in Diabetes Mellitus","volume":"5","author":"Liu","year":"2014","journal-title":"Cell Death Dis."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/s41419-020-03247-6","article-title":"LncRNA LINC00998 Inhibits the Malignant Glioma Phenotype via the CBX3-Mediated c-Met\/Akt\/MTOR Axis","volume":"11","author":"Cai","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ajpath.2018.12.011","article-title":"Potential Biomarkers for Primary Open-Angle Glaucoma Identified by Long Noncoding RNA Profiling in the Aqueous Humor","volume":"189","author":"Xie","year":"2019","journal-title":"Am. J. Pathol."},{"key":"ref_68","first-page":"1329","article-title":"Expression and Clinical Value of LncRNA MALAT1 and LncRNA ANRIL in Glaucoma Patients","volume":"19","author":"Zheng","year":"2020","journal-title":"Exp. Ther. Med."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/8\/1301\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:52:11Z","timestamp":1760136731000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/8\/1301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,12]]},"references-count":68,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,4]]}},"alternative-id":["cells11081301"],"URL":"https:\/\/doi.org\/10.3390\/cells11081301","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,12]]}}}